羊膜穿刺针市场－全球产业规模、份额、趋势、机会及预测，按类型、按程序、按地区及竞争细分，2020-2030 年预测

2024 年全球羊膜穿刺针市场价值为 1.7728 亿美元，预计到 2030 年将达到 2.3609 亿美元，预测期内复合年增长率为 4.85%。羊膜穿刺针是产前诊断中用于提取羊水的重要工具，有助于检测怀孕期间的染色体异常、神经管缺陷和遗传疾病。随着人们越来越意识到早期和准确的产前检测的重要性，对羊膜穿刺（以及羊膜穿刺针）的需求也不断增加。在教育措施和医疗保健进步的支持下，产前诊断的接受度不断提高，推动了市场的成长。此外，在製造商竞争的推动下，针头设计和功能的不断创新正在提高安全性、精确度和成本效益。儘管人们对非侵入性替代方法的兴趣日益浓厚，但羊膜穿刺术仍然是一种黄金标准的诊断程序，确保了羊膜穿刺针解决方案的持续相关性。

关键市场驱动因素

全球孕产妇年龄不断增加

主要市场挑战

替代筛检方法

主要市场趋势

非侵入性产前检测（NIPT）的采用率不断上升

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：羊膜穿刺针市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依类型（100 至 150 毫米针头、大于 150 毫米针头、小于 100 毫米针头）
  • 依手术（羊膜穿刺术、羊水减量术、胎儿输血术、羊膜腔灌注术、脐带穿刺术）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美羊膜穿刺针市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲羊膜穿刺针市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太地区羊膜穿刺针市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲羊膜穿刺针市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲羊膜穿刺针市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 13 章： 大环境分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第十五章：全球羊膜穿刺针市场：SWOT分析

第 16 章：竞争格局

• Becton Dickinson and Company
• The Cooper Companies, Inc.
• Cook Medical Incorporated
• RI.MOS. srl
• Medtronic Plc
• Somatex Medical Technologies
• COOK Medical
• Smiths Medical
• Biopsybell
• IMD

第 17 章：策略建议

第18章调查会社について・免责事项

The Global Amniocentesis Needle Market was valued at USD 177.28 million in 2024 and is projected to reach USD 236.09 million by 2030, growing at a CAGR of 4.85% during the forecast period. Amniocentesis needles are critical tools used in prenatal diagnostics to extract amniotic fluid, aiding in the detection of chromosomal abnormalities, neural tube defects, and genetic disorders during pregnancy. As awareness grows around the importance of early and accurate prenatal testing, demand for amniocentesis procedures-and by extension, amniocentesis needles-is on the rise. Increasing acceptance of prenatal diagnostics, supported by educational initiatives and healthcare advancements, is boosting market growth. Moreover, ongoing innovations in needle design and functionality, driven by manufacturer competition, are enhancing safety, precision, and cost-efficiency. Despite rising interest in non-invasive alternatives, amniocentesis remains a gold standard diagnostic procedure, ensuring sustained relevance for amniocentesis needle solutions.

Key Market Drivers

Increasing Maternal Age Worldwide

The upward trend in maternal age across the globe is significantly influencing demand for prenatal diagnostic procedures like amniocentesis. In countries such as the United States and Germany, the average age of first-time mothers has steadily increased, resulting in a higher number of pregnancies classified as high-risk. This demographic shift correlates with an elevated incidence of chromosomal abnormalities, including Down syndrome and Trisomy 18, particularly in women over 35. As these pregnancies necessitate more thorough prenatal diagnostics, the use of amniocentesis-and consequently, specialized needles for the procedure-becomes increasingly common. In developed nations like Italy, Spain, and South Korea, where the average maternal age is nearing or surpassing 32 years, the demand for accurate and safe diagnostic tools is surging. This global trend toward delayed parenthood, fueled by social and economic factors such as education, career focus, and access to fertility treatments, is a critical driver of growth in the amniocentesis needle market.

Key Market Challenges

Alternative Screening Methods

The growing adoption of alternative screening methods, particularly non-invasive prenatal testing (NIPT), presents a challenge for the amniocentesis needle market. NIPT offers high accuracy in detecting chromosomal abnormalities by analyzing cell-free fetal DNA through a maternal blood sample, reducing the need for invasive testing. These methods are preferred by many expectant parents due to their safety and comfort, as they eliminate the small but real risk associated with amniocentesis. However, while NIPT provides a reliable screening option, it does not deliver a definitive diagnosis, for which amniocentesis remains essential. The increasing use of NIPT may reduce the overall frequency of amniocentesis procedures, impacting the demand for related medical tools, including needles. Nonetheless, in cases requiring confirmation or where detailed genetic analysis is necessary, amniocentesis continues to be indispensable, maintaining its critical role in high-risk pregnancies.

Key Market Trends

Rising Adoption of Non-Invasive Prenatal Testing (NIPT)

Non-Invasive Prenatal Testing (NIPT) is gaining traction as a preferred screening method, significantly shaping the dynamics of the amniocentesis needle market. NIPT enables early detection of chromosomal abnormalities using a maternal blood sample, offering a non-invasive alternative to traditional diagnostic methods. This trend reflects a growing preference for safer, less intrusive prenatal assessments. The appeal of NIPT lies in its ability to deliver accurate results with no risk of complications, enhancing patient comfort and compliance. While this shift may reduce the frequency of invasive procedures like amniocentesis, it's important to note that NIPT is a screening-not diagnostic-tool. Therefore, when definitive diagnosis is necessary, especially in high-risk pregnancies, amniocentesis remains a critical follow-up procedure. As such, the adoption of NIPT is transforming prenatal care but continues to position amniocentesis as an essential diagnostic pathway for comprehensive fetal health evaluation.

Key Market Players

• Becton Dickinson and Company
• The Cooper Companies, Inc.
• Cook Medical Incorporated
• RI.MOS. srl
• Medtronic Plc
• Somatex Medical Technologies
• COOK Medical
• Smiths Medical
• Biopsybell
• IMD

Report Scope:

In this report, the Global Amniocentesis Needle Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Amniocentesis Needle Market, By Type:

• 100 to 150 mm Needles
• Larger Than 150 mm Needles
• Smaller Than 100 mm Needles

Amniocentesis Needle Market, By Procedure:

• Amniocentesis Procedures
• Amnioreduction Procedures
• Fetal Blood Transfusion Procedures
• Amnioinfusion Procedures
• Cordocentesis Procedures

Amniocentesis Needle Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Amniocentesis Needle Market.

Available Customizations:

Global Amniocentesis Needle Market report with the given Market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Amniocentesis Needle Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (100 to 150 mm Needles, Larger Than 150 mm Needles, Smaller Than 100 mm Needles)
  • 5.2.2. By Procedure (Amniocentesis Procedures, Amnioreduction Procedures, Fetal Blood Transfusion Procedures, Amnioinfusion Procedures, Cordocentesis Procedures)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Amniocentesis Needle Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Procedure
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Amniocentesis Needle Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Procedure
  • 6.3.2. Canada Amniocentesis Needle Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Procedure
  • 6.3.3. Mexico Amniocentesis Needle Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Procedure

7. Europe Amniocentesis Needle Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Procedure
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Amniocentesis Needle Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Procedure
  • 7.3.2. United Kingdom Amniocentesis Needle Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Procedure
  • 7.3.3. Italy Amniocentesis Needle Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Procedure
  • 7.3.4. France Amniocentesis Needle Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Procedure
  • 7.3.5. Spain Amniocentesis Needle Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Procedure

8. Asia-Pacific Amniocentesis Needle Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Procedure
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Amniocentesis Needle Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Procedure
  • 8.3.2. India Amniocentesis Needle Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Procedure
  • 8.3.3. Japan Amniocentesis Needle Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Procedure
  • 8.3.4. South Korea Amniocentesis Needle Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Procedure
  • 8.3.5. Australia Amniocentesis Needle Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Procedure

9. South America Amniocentesis Needle Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Procedure
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Amniocentesis Needle Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Procedure
  • 9.3.2. Argentina Amniocentesis Needle Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Procedure
  • 9.3.3. Colombia Amniocentesis Needle Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Procedure

10. Middle East and Africa Amniocentesis Needle Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Procedure
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Amniocentesis Needle Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Procedure
  • 10.3.2. Saudi Arabia Amniocentesis Needle Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Procedure
  • 10.3.3. UAE Amniocentesis Needle Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Procedure

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Global Amniocentesis Needle Market: SWOT Analysis

16. Competitive Landscape

• 16.1. Becton Dickinson and Company
  • 16.1.1. Business Overview
  • 16.1.2. Product & Service Offerings
  • 16.1.3. Recent Developments
  • 16.1.4. Financials (If Listed)
  • 16.1.5. Key Personnel
  • 16.1.6. SWOT Analysis
• 16.2. The Cooper Companies, Inc.
• 16.3. Cook Medical Incorporated
• 16.4. RI.MOS. srl
• 16.5. Medtronic Plc
• 16.6. Somatex Medical Technologies
• 16.7. COOK Medical
• 16.8. Smiths Medical
• 16.9. Biopsybell
• 16.10.IMD

17. Strategic Recommendations

18. About Us & Disclaimer